Biblio Discovery — Demo Discovery Service

10 results for "Andrew Protheroe"

Showing 1–10 · 0.34 seconds · RSS

  1. Journal Article

    Case report of oxalate nephropathy in a patient with pancreatic metastases from renal carcinoma

    Karin Purshouse; Sarah Chamberlain; Maria Soares et al.

    BMC Cancer, Vol. 19 No. 1 · 2019 · English · DOAJ Scopus

    Abstract Background Patients with metastatic renal carcinoma frequently have pre-existing renal impairment and not infrequently develop worsening renal function as a complication of their treatment. The presence of pancreatic metastases in patients with metastatic renal carcinoma, often confers a…

  2. Journal Article

    Cabozantinib and Axitinib After Vascular Endothelial Growth Factor Therapy in Patients with Advanced Renal Cell Carcinoma: A Retrospective Cohort Study from England

    Janet Brown; Brooke Harrow; Anne Marciniak et al.

    Drugs - Real World Outcomes, Vol. 11 No. 2 · 2024 · English · DOAJ Scopus

    Abstract Background and Objective The tyrosine kinase inhibitors cabozantinib and axitinib have been widely used in England to treat advanced renal cell carcinoma following prior vascular endothelial growth factor-targeted therapy, but data on real-world usage remain limited. Our objective was to…

  3. Journal Article Full text

    The Use of Digital Pathology and Artificial Intelligence in Histopathological Diagnostic Assessment of Prostate Cancer: A Survey of Prostate Cancer UK Supporters

    Kai Rakovic; Richard Colling; Lisa Browning et al.

    Diagnostics, Vol. 12 No. 5 · 2022 · English · DOAJ Scopus

    There has been particular interest in the deployment of digital pathology (DP) and artificial intelligence (AI) in the diagnosis of prostate cancer, but little is known about the views of the public on their use. Prostate Cancer UK supporters were invited to an online survey which included…

  4. Journal Article

    Real world, multicentre patterns of treatment and survival in metastatic renal cell carcinoma with the UK Renal Oncology Collaborative (UK ROC): Is it time to look favourably on first‐line immunotherapy containing combinations in all IMDC groups?

    John McGrane; Ricky Frazer; Amarnath Challapalli et al.

    Cancer Medicine, Vol. 13 No. 12 · 2024 · English · DOAJ Scopus

    Abstract Introduction Clinical trials show improved progression‐free survival (PFS) and overall survival (OS) in first‐line metastatic renal cell carcinoma (mRCC) patients with immunotherapy containing systemic anti‐cancer therapies (SACT). However, in the favourable international metastatic renal…

  5. Journal Article

    Safety and immunogenicity of novel 5T4 viral vectored vaccination regimens in early stage prostate cancer: a phase I clinical trial

    Andrew Protheroe; Clare Verrill; Thomas Evans et al.

    Journal for ImmunoTherapy of Cancer, Vol. 8 No. 1 · 2020 · English · DOAJ Scopus

    Background Prostate cancer (PCa) has been under investigation as a target for antigen-specific immunotherapies in metastatic disease settings for the last two decades leading to a licensure of the first therapeutic cancer vaccine, Sipuleucel-T, in 2010. However, neither Sipuleucel-T nor other…

  6. Journal Article

    The WIRE study a phase II, multi-arm, multi-centre, non-randomised window-of-opportunity clinical trial platform using a Bayesian adaptive design for proof-of-mechanism of novel treatment strategies in operable renal cell cancer – a study protocol

    Stephan Ursprung; Helen Mossop; Ferdia A. Gallagher et al.

    BMC Cancer, Vol. 21 No. 1 · 2021 · English · DOAJ Scopus

    Abstract Background Window-of-opportunity trials, evaluating the engagement of drugs with their biological target in the time period between diagnosis and standard-of-care treatment, can help prioritise promising new systemic treatments for later-phase clinical trials. Renal cell carcinoma (RCC)…

  7. Journal Article Full text

    Digital Pathology Transformation in a Supraregional Germ Cell Tumour Network

    Richard Colling; Andrew Protheroe; Mark Sullivan et al.

    Diagnostics, Vol. 11 No. 12 · 2021 · English · DOAJ Scopus

    Background: In this article we share our experience of creating a digital pathology (DP) supraregional germ cell tumour service, including full digitisation of the central laboratory. Methods: DP infrastructure (Philips) was deployed across our hospital network to allow full central digitisation…

  8. Journal Article

    An evaluation of artificial intelligence assisted prostate biopsy reporting in the Articulate Pro study

    Lisa Browning; Richard T. Colling; Jon Oxley et al.

    npj Digital Medicine, Vol. 9 No. 1 · 2026 · English · DOAJ Scopus

    Abstract Prospective evidence on clinical utility of AI in histopathology is limited. We conducted a prospective study across three National Health Service specialist centres in England to evaluate a commercially available AI system for assistance in prostate biopsy reporting. Of 1613 cases, 1049…

  9. Journal Article

    Genomic landscape of adult testicular germ cell tumours in the 100,000 Genomes Project

    Máire Ní Leathlobhair; Anna Frangou; Ben Kinnersley et al.

    Nature Communications, Vol. 15 No. 1 · 2024 · English · DOAJ Scopus

    Abstract Testicular germ cell tumours (TGCT), which comprise seminoma and non-seminoma subtypes, are the most common cancers in young men. In this study, we present a comprehensive whole genome sequencing analysis of adult TGCTs. Leveraging samples from participants recruited via the UK National…

  10. Journal Article

    A population-scale temporal case–control evaluation of COVID-19 disease phenotype and related outcome rates in patients with cancer in England (UKCCP)

    Thomas Starkey; Maria C. Ionescu; Michael Tilby et al.

    Scientific Reports, Vol. 13 No. 1 · 2023 · English · DOAJ Scopus

    Abstract Patients with cancer are at increased risk of hospitalisation and mortality following severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. However, the SARS-CoV-2 phenotype evolution in patients with cancer since 2020 has not previously been described. We therefore…